Liquid Biopsy Market Size, Share & Trends Analysis Report By Biomarker, By Technology, By Sample Type, By Application, By Clinical Application, By End Use, By Product, By Region, And Segment Forecasts, 2026 - 2033

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation
  • 1.1.1. Market Definitions
• 1.2. Objectives
  • 1.2.1. OBJECTIVE - 1
  • 1.2.2. OBJECTIVE - 2
  • 1.2.3. OBJECTIVE - 3
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. PURCHASED DATABASE
  • 1.4.2. GVR'S INTERNAL DATABASE
  • 1.4.3. SECONDARY SOURCES
  • 1.4.4. PRIMARY RESEARCH
• 1.5. Information or Data Analysis
  • 1.5.1. DATA ANALYSIS MODELS
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. COMMODITY FLOW ANALYSIS
• 1.8. List of Secondary Sources
• 1.9. List of Abbreviations
• 1.10. List of Primary Sources

Chapter 2. Executive Summary

• 2.1. Market Snapshot
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

• 3.1. Market Segmentation and Scope
• 3.2. Market Lineage Outlook
  • 3.2.1. Parent Market Outlook
  • 3.2.2. Related/Ancillary Market Outlook
• 3.3. Market Dynamics
• 3.4. Market Drivers
  • 3.4.1. Increasing prevalence of cancer
  • 3.4.2. Growing geriatric population
  • 3.4.3. Technological advancements
  • 3.4.4. Increasing preference for noninvasive treatment
• 3.5. Market Restraint Analysis
  • 3.5.1. Patent expiry of blockbuster drugs prescribed
• 3.6. Business Environment Analysis
  • 3.6.1. SWOT Analysis; By Factor (Political & Legal, Economic And Technological)
  • 3.6.2. Porter's Five Forces Analysis

Chapter 4. Sample Type Business Analysis

• 4.1. Liquid Biopsy Market: Type Movement Analysis
• 4.2. Blood Sample
  • 4.2.1. Blood Sample Market, 2021 - 2033 (USD Million)
• 4.3. Others
  • 4.3.1. Others Market, 2021 - 2033 (USD Million)

Chapter 5. Biomarker Business Analysis

• 5.1. Liquid Biopsy Market: Biomarker Movement Analysis
• 5.2. Circulating Tumor Cells (CTCs)
  • 5.2.1. Circulating Tumor Cells (CTCs) Market, 2021 - 2033 (USD Million)
• 5.3. Circulating Nucleic Acids
  • 5.3.1. Circulating Nucleic Acids Market, 2021 - 2033 (USD Million)
• 5.4. Exosomes/Microvesicles
  • 5.4.1. Exosomes/Microvesicles Market, 2021 - 2033 (USD Million)
• 5.5. Others
  • 5.5.1. Others Market, 2021 - 2033 (USD Million)

Chapter 6. Technology Business Analysis

• 6.1. Liquid Biopsy Market: Technology Movement Analysis
• 6.2. Multi-gene-parallel Analysis (NGS)
  • 6.2.1. Multi-gene-parallel Analysis (NGS) Market, 2021 - 2033 (USD Million)
• 6.3. Single Gene Analysis (PCR Microarrays)
  • 6.3.1. Single Gene Analysis (PCR Microarrays) Market, 2021 - 2033 (USD Million)

Chapter 7. Application Business Analysis

• 7.1. Liquid Biopsy Market: Application Movement Analysis
• 7.2. Cancer
  • 7.2.1. Cancer Market, 2021 - 2033 (USD Million)
    • 7.2.1.1. Lung Cancer
      • 7.2.1.1.1. Lung Cancer Market, 2021 - 2033 (USD Million)
    • 7.2.1.2. Prostate Cancer
      • 7.2.1.2.1. Prostate Cancer Market, 2021 - 2033 (USD Million)
    • 7.2.1.3. Breast Cancer
      • 7.2.1.3.1. Breast Cancer Market, 2021 - 2033 (USD Million)
    • 7.2.1.4. Colorectal Cancer
      • 7.2.1.4.1. Colorectal Cancer Market, 2021 - 2033 (USD Million)
    • 7.2.1.5. Leukemia
      • 7.2.1.5.1. Leukemia Market, 2021 - 2033 (USD Million)
    • 7.2.1.6. Gastrointestinal Cancer
      • 7.2.1.6.1. Gastrointestinal Cancer Market, 2021 - 2033 (USD Million)
    • 7.2.1.7. Others
      • 7.2.1.7.1. Others Market, 2021 - 2033 (USD Million)
• 7.3. Reproductive Health
  • 7.3.1. Reproductive Health Market, 2021 - 2033 (USD Million)
• 7.4. Others
  • 7.4.1. Others Market, 2021 - 2033 (USD Million)

Chapter 8. End Use Business Analysis

• 8.1. Liquid Biopsy Market: End-Use Movement Analysis
• 8.2. Hospitals and Laboratories
  • 8.2.1. Hospitals and Laboratories Market, 2021 - 2033 (USD Million)
• 8.3. Specialty Clinics
  • 8.3.1. Specialty Clinics Market, 2021 - 2033 (USD Million)
• 8.4. Academic and Research Centers
  • 8.4.1. Academic and Research Centers Market, 2021 - 2033 (USD Million)
• 8.5. Others
  • 8.5.1. Others Liquid Biopsy Market, 2021 - 2033 (USD Million)

Chapter 9. Clinical Application Business Analysis

• 9.1. Liquid Biopsy Market: Clinical Application Movement Analysis
• 9.2. Therapy Selection
  • 9.2.1. Therapy Selection Market, 2021 - 2033 (USD Million)
• 9.3. Treatment Monitoring
  • 9.3.1. Treatment Monitoring Market, 2021 - 2033 (USD Million)
• 9.4. Early Cancer Screening
  • 9.4.1. Early Cancer Screening Market, 2021 - 2033 (USD Million)
• 9.5. Recurrence Monitoring
  • 9.5.1. Recurrence Monitoring Market, 2021 - 2033 (USD Million)
• 9.6. Others
  • 9.6.1. Others Liquid Biopsy Market, 2021 - 2033 (USD Million)

Chapter 10. Product Business Analysis

• 10.1. Liquid Biopsy Market: Product Movement Analysis
• 10.2. Instruments
  • 10.2.1. Instruments Market, 2021 - 2033 (USD Million)
• 10.3. Consumables Kits and Reagents
  • 10.3.1. Consumables Kits and Reagents Market, 2021 - 2033 (USD Million)
• 10.4. Software and Services
  • 10.4.1. Software and Services Market, 2021 - 2033 (USD Million)

Chapter 11. Regional Business Analysis

• 11.1. Liquid Biopsy Market Share By Region, 2025 & 2033
• 11.2. North America
  • 11.2.1. North America Liquid biopsy market, 2021 - 2033 (USD Million)
  • 11.2.2. U.S.
    • 11.2.2.1. Key Country Dynamics
    • 11.2.2.2. Target Disease Prevalence
    • 11.2.2.3. Competitive Scenario
    • 11.2.2.4. Regulatory Framework
    • 11.2.2.5. Reimbursement Scenario
    • 11.2.2.6. U.S. Liquid biopsy market, 2021 - 2033 (USD MILLION)
  • 11.2.3. Canada
    • 11.2.3.1. Key Country Dynamics
    • 11.2.3.2. Target Disease Prevalence
    • 11.2.3.3. Competitive Scenario
    • 11.2.3.4. Regulatory Framework
    • 11.2.3.5. Reimbursement Scenario
    • 11.2.3.6. Canada Liquid biopsy market, 2021 - 2033 (USD Million)
  • 11.2.4. Mexico
    • 11.2.4.1. Key Country Dynamics
    • 11.2.4.2. Target Disease Prevalence
    • 11.2.4.3. Competitive Scenario
    • 11.2.4.4. Regulatory Framework
    • 11.2.4.5. Reimbursement Scenario
    • 11.2.4.6. Mexico Liquid biopsy market, 2021 - 2033 (USD Million)
• 11.3. Europe
  • 11.3.1. Europe Liquid biopsy market, 2021 - 2033 (USD Million)
  • 11.3.2. Germany
    • 11.3.2.1. Key Country Dynamics
    • 11.3.2.2. Target Disease Prevalence
    • 11.3.2.3. Competitive Scenario
    • 11.3.2.4. Regulatory Framework
    • 11.3.2.5. Reimbursement Scenario
    • 11.3.2.6. Germany Liquid biopsy market, 2021 - 2033 (USD Million)
  • 11.3.3. UK
    • 11.3.3.1. Key Country Dynamics
    • 11.3.3.2. Target Disease Prevalence
    • 11.3.3.3. Competitive Scenario
    • 11.3.3.4. Regulatory Framework
    • 11.3.3.5. Reimbursement Scenario
    • 11.3.3.6. UK Liquid biopsy market, 2021 - 2033 (USD Million)
  • 11.3.4. France
    • 11.3.4.1. Key Country Dynamics
    • 11.3.4.2. Target Disease Prevalence
    • 11.3.4.3. Competitive Scenario
    • 11.3.4.4. Regulatory Framework
    • 11.3.4.5. Reimbursement Scenario
    • 11.3.4.6. France Liquid biopsy market, 2021 - 2033 (USD Million)
  • 11.3.5. Italy
    • 11.3.5.1. Key Country Dynamics
    • 11.3.5.2. Target Disease Prevalence
    • 11.3.5.3. Competitive Scenario
    • 11.3.5.4. Regulatory Framework
    • 11.3.5.5. Reimbursement Scenario
    • 11.3.5.6. Italy Liquid biopsy market, 2021 - 2033 (USD Million)
  • 11.3.6. Spain
    • 11.3.6.1. Key Country Dynamics
    • 11.3.6.2. Target Disease Prevalence
    • 11.3.6.3. Competitive Scenario
    • 11.3.6.4. Regulatory Framework
    • 11.3.6.5. Reimbursement Scenario
    • 11.3.6.6. Spain Liquid biopsy market, 2021 - 2033 (USD Million)
  • 11.3.7. Denmark
    • 11.3.7.1. Key Country Dynamics
    • 11.3.7.2. Target Disease Prevalence
    • 11.3.7.3. Competitive Scenario
    • 11.3.7.4. Regulatory Framework
    • 11.3.7.5. Reimbursement Scenario
    • 11.3.7.6. Denmark Liquid biopsy market, 2021 - 2033 (USD Million)
  • 11.3.8. Sweden
    • 11.3.8.1. Key Country Dynamics
    • 11.3.8.2. Target Disease Prevalence
    • 11.3.8.3. Competitive Scenario
    • 11.3.8.4. Regulatory Framework
    • 11.3.8.5. Reimbursement Scenario
    • 11.3.8.6. Sweden Liquid biopsy market, 2021 - 2033 (USD Million)
  • 11.3.9. Norway
    • 11.3.9.1. Key Country Dynamics
    • 11.3.9.2. Target Disease Prevalence
    • 11.3.9.3. Competitive Scenario
    • 11.3.9.4. Regulatory Framework
    • 11.3.9.5. Reimbursement Scenario
    • 11.3.9.6. Norway Liquid biopsy market, 2021 - 2033 (USD Million)
• 11.4. Asia Pacific
  • 11.4.1. Asia Pacific Liquid biopsy market, 2021 - 2033 (USD Million)
  • 11.4.2. Japan
    • 11.4.2.1. Key Country Dynamics
    • 11.4.2.2. Target Disease Prevalence
    • 11.4.2.3. Competitive Scenario
    • 11.4.2.4. Regulatory Framework
    • 11.4.2.5. Reimbursement Scenario
    • 11.4.2.6. Japan Liquid biopsy market, 2021 - 2033 (USD Million)
  • 11.4.3. China
    • 11.4.3.1. Key Country Dynamics
    • 11.4.3.2. Target Disease Prevalence
    • 11.4.3.3. Competitive Scenario
    • 11.4.3.4. Regulatory Framework
    • 11.4.3.5. Reimbursement Scenario
    • 11.4.3.6. China Liquid biopsy market, 2021 - 2033 (USD Million)
  • 11.4.4. India
    • 11.4.4.1. Key Country Dynamics
    • 11.4.4.2. Target Disease Prevalence
    • 11.4.4.3. Competitive Scenario
    • 11.4.4.4. Regulatory Framework
    • 11.4.4.5. Reimbursement Scenario
    • 11.4.4.6. India Liquid biopsy market, 2021 - 2033 (USD Million)
  • 11.4.5. South Korea
    • 11.4.5.1. Key Country Dynamics
    • 11.4.5.2. Target Disease Prevalence
    • 11.4.5.3. Competitive Scenario
    • 11.4.5.4. Regulatory Framework
    • 11.4.5.5. Reimbursement Scenario
    • 11.4.5.6. South Korea Liquid biopsy market, 2021 - 2033 (USD Million)
  • 11.4.6. Australia
    • 11.4.6.1. Key Country Dynamics
    • 11.4.6.2. Target Disease Prevalence
    • 11.4.6.3. Competitive Scenario
    • 11.4.6.4. Regulatory Framework
    • 11.4.6.5. Reimbursement Scenario
    • 11.4.6.6. Australia Liquid biopsy market, 2021 - 2033 (USD Million)
  • 11.4.7. Thailand
    • 11.4.7.1. Key Country Dynamics
    • 11.4.7.2. Target Disease Prevalence
    • 11.4.7.3. Competitive Scenario
    • 11.4.7.4. Regulatory Framework
    • 11.4.7.5. Reimbursement Scenario
    • 11.4.7.6. Thailand Liquid biopsy market, 2021 - 2033 (USD Million)
• 11.5. Latin America
  • 11.5.1. Latin America Liquid biopsy market, 2021 - 2033 (USD Million)
  • 11.5.2. Brazil
    • 11.5.2.1. Key Country Dynamics
    • 11.5.2.2. Target Disease Prevalence
    • 11.5.2.3. Competitive Scenario
    • 11.5.2.4. Regulatory Framework
    • 11.5.2.5. Reimbursement Scenario
    • 11.5.2.6. Brazil Liquid biopsy market, 2021 - 2033 (USD Million)
  • 11.5.3. Argentina
    • 11.5.3.1. Key Country Dynamics
    • 11.5.3.2. Target Disease Prevalence
    • 11.5.3.3. Competitive Scenario
    • 11.5.3.4. Regulatory Framework
    • 11.5.3.5. Reimbursement Scenario
    • 11.5.3.6. Argentina Liquid biopsy market, 2021 - 2033 (USD Million)
• 11.6. Middle East and Africa
  • 11.6.1. Middle East and Africa Liquid biopsy market, 2021 - 2033 (USD Million)
  • 11.6.2. South Africa
    • 11.6.2.1. Key Country Dynamics
    • 11.6.2.2. Target Disease Prevalence
    • 11.6.2.3. Competitive Scenario
    • 11.6.2.4. Regulatory Framework
    • 11.6.2.5. Reimbursement Scenario
    • 11.6.2.6. South Africa Liquid biopsy market, 2021 - 2033 (USD Million)
  • 11.6.3. Saudi Arabia
    • 11.6.3.1. Key Country Dynamics
    • 11.6.3.2. Target Disease Prevalence
    • 11.6.3.3. Competitive Scenario
    • 11.6.3.4. Regulatory Framework
    • 11.6.3.5. Reimbursement Scenario
    • 11.6.3.6. Saudi Arabia Liquid biopsy market, 2021 - 2033 (USD Million)
  • 11.6.4. UAE
    • 11.6.4.1. Key Country Dynamics
    • 11.6.4.2. Target Disease Prevalence
    • 11.6.4.3. Competitive Scenario
    • 11.6.4.4. Regulatory Framework
    • 11.6.4.5. Reimbursement Scenario
    • 11.6.4.6. UAE Liquid biopsy market, 2021 - 2033 (USD Million)
  • 11.6.5. Kuwait
    • 11.6.5.1. Key Country Dynamics
    • 11.6.5.2. Target Disease Prevalence
    • 11.6.5.3. Competitive Scenario
    • 11.6.5.4. Regulatory Framework
    • 11.6.5.5. Reimbursement Scenario
    • 11.6.5.6. Kuwait Liquid biopsy market, 2021 - 2033 (USD Million)

Chapter 12. Competitive Landscape

• 12.1. Participant's overview
• 12.2. Financial performance
• 12.3. Participant categorization
  • 12.3.1. Market Leaders
  • 12.3.2. Liquid Biopsy Market Share Analysis, 2025
  • 12.3.3. Company Profiles
    • 12.3.3.1. ANGLE plc
      • 12.3.3.1.1. Company Overview
      • 12.3.3.1.2. Financial Performance
      • 12.3.3.1.3. Product Benchmarking
      • 12.3.3.1.4. Strategic Initiatives
    • 12.3.3.2. Oncimmune Holdings PLC
      • 12.3.3.2.1. Company Overview
      • 12.3.3.2.2. Financial Performance
      • 12.3.3.2.3. Product Benchmarking
      • 12.3.3.2.4. Strategic Initiatives
    • 12.3.3.3. Guardant Health
      • 12.3.3.3.1. Company Overview
      • 12.3.3.3.2. Financial Performance
      • 12.3.3.3.3. Product Benchmarking
      • 12.3.3.3.4. Strategic Initiatives
    • 12.3.3.4. Myriad Genetics, Inc.
      • 12.3.3.4.1. Company Overview
      • 12.3.3.4.2. Financial Performance
      • 12.3.3.4.3. Product Benchmarking
      • 12.3.3.4.4. Strategic Initiatives
    • 12.3.3.5. Biocept, Inc.
      • 12.3.3.5.1. Company Overview
      • 12.3.3.5.2. Financial Performance
      • 12.3.3.5.3. Product Benchmarking
      • 12.3.3.5.4. Strategic Initiatives
    • 12.3.3.6. Lucence Health Inc.
      • 12.3.3.6.1. Company Overview
      • 12.3.3.6.2. Financial Performance
      • 12.3.3.6.3. Product Benchmarking
      • 12.3.3.6.4. Strategic Initiatives
    • 12.3.3.7. Freenome Holdings, Inc.
      • 12.3.3.7.1. Company Overview
      • 12.3.3.7.2. Financial Performance
      • 12.3.3.7.3. Product Benchmarking
      • 12.3.3.7.4. Strategic Initiatives
    • 12.3.3.8. F. Hoffmann-La Roche Ltd.
      • 12.3.3.8.1. Company Overview
      • 12.3.3.8.2. Financial Performance
      • 12.3.3.8.3. Product Benchmarking
      • 12.3.3.8.4. Strategic Initiatives
    • 12.3.3.9. QIAGEN
      • 12.3.3.9.1. Company Overview
      • 12.3.3.9.2. Financial Performance
      • 12.3.3.9.3. Product Benchmarking
      • 12.3.3.9.4. Strategic Initiatives
    • 12.3.3.10. Illumina, Inc.
      • 12.3.3.10.1. Company Overview
      • 12.3.3.10.2. Financial Performance
      • 12.3.3.10.3. Product Benchmarking
      • 12.3.3.10.4. Strategic Initiatives
    • 12.3.3.11. Thermo Fisher Scientific, Inc.
      • 12.3.3.11.1. Company Overview
      • 12.3.3.11.2. Financial Performance
      • 12.3.3.11.3. Product Benchmarking
      • 12.3.3.11.4. Strategic Initiatives
    • 12.3.3.12. Epigenomics AG
      • 12.3.3.12.1. Company Overview
      • 12.3.3.12.2. Financial Performance
      • 12.3.3.12.3. Product Benchmarking
      • 12.3.3.12.4. Strategic Initiatives
  • 12.3.4. Strategy Mapping
    • 12.3.4.1. Expansion
    • 12.3.4.2. Acquisition
    • 12.3.4.3. Collaborations
    • 12.3.4.4. Disease Type/Drug Class Launch
    • 12.3.4.5. Partnerships
    • 12.3.4.6. Others

List of Tables

• Table 1 List of Tables
• Table 2 Global Liquid Biopsy Market, By Region, 2021 - 2033 (USD Million)
• Table 3 Global Liquid Biopsy Market, By Sample Type, 2021 - 2033 (USD Million)
• Table 4 Global Liquid Biopsy Market, By Biomarker, 2021 - 2033 (USD Million)
• Table 5 Global Liquid Biopsy Market, By Technology, 2021 - 2033 (USD Million)
• Table 6 Global Liquid Biopsy Market, By Application, 2021 - 2033 (USD Million)
• Table 7 Global Liquid Biopsy Market, By End Use, 2021 - 2033 (USD Million)
• Table 8 Global Liquid Biopsy Market, By Clinical Application, 2021 - 2033 (USD Million)
• Table 9 Global Liquid Biopsy Market, By Product, 2021 - 2033 (USD Million)
• Table 10 North America Liquid Biopsy Market, By Country, 2021 - 2033 (USD Million)
• Table 11 North America Liquid Biopsy Market, By Sample Type, 2021 - 2033 (USD Million)
• Table 12 North America Liquid Biopsy Market, By Biomarker, 2021 - 2033 (USD Million)
• Table 13 North America Liquid Biopsy Market, By Technology, 2021 - 2033 (USD Million)
• Table 14 North America Liquid Biopsy Market, By Application, 2021 - 2033 (USD Million)
• Table 15 North America Liquid Biopsy Market, By End Use, 2021 - 2033 (USD Million)
• Table 16 North America Liquid Biopsy Market, By Clinical Application, 2021 - 2033 (USD Million)
• Table 17 North America Liquid Biopsy Market, By Product, 2021 - 2033 (USD Million)
• Table 18 U.S. Liquid Biopsy Market, By Sample Type, 2021 - 2033 (USD Million)
• Table 19 U.S. Liquid Biopsy Market, By Biomarker, 2021 - 2033 (USD Million)
• Table 20 U.S. Liquid Biopsy Market, By Technology, 2021 - 2033 (USD Million)
• Table 21 U.S. Liquid Biopsy Market, By Application, 2021 - 2033 (USD Million)
• Table 22 U.S. Liquid Biopsy Market, By End Use, 2021 - 2033 (USD Million)
• Table 23 U.S. Liquid Biopsy Market, By Clinical Application, 2021 - 2033 (USD Million)
• Table 24 U.S. Liquid Biopsy Market, By Product, 2021 - 2033 (USD Million)
• Table 25 Canada Liquid Biopsy Market, By Sample Type, 2021 - 2033 (USD Million)
• Table 26 Canada Liquid Biopsy Market, By Biomarker, 2021 - 2033 (USD Million)
• Table 27 Canada Liquid Biopsy Market, By Technology, 2021 - 2033 (USD Million)
• Table 28 Canada Liquid Biopsy Market, By Application, 2021 - 2033 (USD Million)
• Table 29 Canada Liquid Biopsy Market, By End Use, 2021 - 2033 (USD Million)
• Table 30 Canada Liquid Biopsy Market, By Clinical Application, 2021 - 2033 (USD Million)
• Table 31 Canada Liquid Biopsy Market, By Product, 2021 - 2033 (USD Million)
• Table 32 Mexico Liquid Biopsy Market, By Sample Type, 2021 - 2033 (USD Million)
• Table 33 Mexico Liquid Biopsy Market, By Biomarker, 2021 - 2033 (USD Million)
• Table 34 Mexico Liquid Biopsy Market, By Technology, 2021 - 2033 (USD Million)
• Table 35 Mexico Liquid Biopsy Market, By Application, 2021 - 2033 (USD Million)
• Table 36 Mexico Liquid Biopsy Market, By End Use, 2021 - 2033 (USD Million)
• Table 37 Mexico Liquid Biopsy Market, By Clinical Application, 2021 - 2033 (USD Million)
• Table 38 Mexico Liquid Biopsy Market, By Product, 2021 - 2033 (USD Million)
• Table 39 Europe Liquid Biopsy Market, By Country, 2021 - 2033 (USD Million)
• Table 40 Europe Liquid Biopsy Market, By Sample Type, 2021 - 2033 (USD Million)
• Table 41 Europe Liquid Biopsy Market, By Biomarker, 2021 - 2033 (USD Million)
• Table 42 Europe Liquid Biopsy Market, By Technology, 2021 - 2033 (USD Million)
• Table 43 Europe Liquid Biopsy Market, By Application, 2021 - 2033 (USD Million)
• Table 44 Europe Liquid Biopsy Market, By End Use, 2021 - 2033 (USD Million)
• Table 45 Europe Liquid Biopsy Market, By Clinical Application, 2021 - 2033 (USD Million)
• Table 46 Europe Liquid Biopsy Market, By Product, 2021 - 2033 (USD Million)
• Table 47 UK Liquid Biopsy Market, By Sample Type, 2021 - 2033 (USD Million)
• Table 48 UK Liquid Biopsy Market, By Biomarker, 2021 - 2033 (USD Million)
• Table 49 UK Liquid Biopsy Market, By Technology, 2021 - 2033 (USD Million)
• Table 50 UK Liquid Biopsy Market, By Application, 2021 - 2033 (USD Million)
• Table 51 UK Liquid Biopsy Market, By End Use, 2021 - 2033 (USD Million)
• Table 52 UK Liquid Biopsy Market, By Clinical Application, 2021 - 2033 (USD Million)
• Table 53 UK Liquid Biopsy Market, By Product, 2021 - 2033 (USD Million)
• Table 54 Germany Liquid Biopsy Market, By Sample Type, 2021 - 2033 (USD Million)
• Table 55 Germany Liquid Biopsy Market, By Biomarker, 2021 - 2033 (USD Million)
• Table 56 Germany Liquid Biopsy Market, By Technology, 2021 - 2033 (USD Million)
• Table 57 Germany Liquid Biopsy Market, By Application, 2021 - 2033 (USD Million)
• Table 58 Germany Liquid Biopsy Market, By End Use, 2021 - 2033 (USD Million)
• Table 59 Germany Liquid Biopsy Market, By Clinical Application, 2021 - 2033 (USD Million)
• Table 60 Germany Liquid Biopsy Market, By Product, 2021 - 2033 (USD Million)
• Table 61 France Liquid Biopsy Market, By Sample Type, 2021 - 2033 (USD Million)
• Table 62 France Liquid Biopsy Market, By Biomarker, 2021 - 2033 (USD Million)
• Table 63 France Liquid Biopsy Market, By Technology, 2021 - 2033 (USD Million)
• Table 64 France Liquid Biopsy Market, By Application, 2021 - 2033 (USD Million)
• Table 65 France Liquid Biopsy Market, By End Use, 2021 - 2033 (USD Million)
• Table 66 France Liquid Biopsy Market, By Clinical Application, 2021 - 2033 (USD Million)
• Table 67 France Liquid Biopsy Market, By Product, 2021 - 2033 (USD Million)
• Table 68 Italy Liquid Biopsy Market, By Sample Type, 2021 - 2033 (USD Million)
• Table 69 Italy Liquid Biopsy Market, By Biomarker, 2021 - 2033 (USD Million)
• Table 70 Italy Liquid Biopsy Market, By Technology, 2021 - 2033 (USD Million)
• Table 71 Italy Liquid Biopsy Market, By Application, 2021 - 2033 (USD Million)
• Table 72 Italy Liquid Biopsy Market, By End Use, 2021 - 2033 (USD Million)
• Table 73 Italy Liquid Biopsy Market, By Clinical Application, 2021 - 2033 (USD Million)
• Table 74 Italy Liquid Biopsy Market, By Product, 2021 - 2033 (USD Million)
• Table 75 Spain Liquid Biopsy Market, By Sample Type, 2021 - 2033 (USD Million)
• Table 76 Spain Liquid Biopsy Market, By Biomarker, 2021 - 2033 (USD Million)
• Table 77 Spain Liquid Biopsy Market, By Technology, 2021 - 2033 (USD Million)
• Table 78 Spain Liquid Biopsy Market, By Application, 2021 - 2033 (USD Million)
• Table 79 Spain Liquid Biopsy Market, By End Use, 2021 - 2033 (USD Million)
• Table 80 Spain Liquid Biopsy Market, By Clinical Application, 2021 - 2033 (USD Million)
• Table 81 Spain Liquid Biopsy Market, By Product, 2021 - 2033 (USD Million)
• Table 82 Denmark Liquid Biopsy Market, By Sample Type, 2021 - 2033 (USD Million)
• Table 83 Denmark Liquid Biopsy Market, By Biomarker, 2021 - 2033 (USD Million)
• Table 84 Denmark Liquid Biopsy Market, By Technology, 2021 - 2033 (USD Million)
• Table 85 Denmark Liquid Biopsy Market, By Application, 2021 - 2033 (USD Million)
• Table 86 Denmark Liquid Biopsy Market, By End Use, 2021 - 2033 (USD Million)
• Table 87 Denmark Liquid Biopsy Market, By Clinical Application, 2021 - 2033 (USD Million)
• Table 88 Denmark Liquid Biopsy Market, By Product, 2021 - 2033 (USD Million)
• Table 89 Sweden Liquid Biopsy Market, By Sample Type, 2021 - 2033 (USD Million)
• Table 90 Sweden Liquid Biopsy Market, By Biomarker, 2021 - 2033 (USD Million)
• Table 91 Sweden Liquid Biopsy Market, By Technology, 2021 - 2033 (USD Million)
• Table 92 Sweden Liquid Biopsy Market, By Application, 2021 - 2033 (USD Million)
• Table 93 Sweden Liquid Biopsy Market, By End Use, 2021 - 2033 (USD Million)
• Table 94 Sweden Liquid Biopsy Market, By Clinical Application, 2021 - 2033 (USD Million)
• Table 95 Sweden Liquid Biopsy Market, By Product, 2021 - 2033 (USD Million)
• Table 96 Norway Liquid Biopsy Market, By Sample Type, 2021 - 2033 (USD Million)
• Table 97 Norway Liquid Biopsy Market, By Biomarker, 2021 - 2033 (USD Million)
• Table 98 Norway Liquid Biopsy Market, By Technology, 2021 - 2033 (USD Million)
• Table 99 Norway Liquid Biopsy Market, By Application, 2021 - 2033 (USD Million)
• Table 100 Norway Liquid Biopsy Market, By End Use, 2021 - 2033 (USD Million)
• Table 101 Norway Liquid Biopsy Market, By Clinical Application, 2021 - 2033 (USD Million)
• Table 102 Norway Liquid Biopsy Market, By Product, 2021 - 2033 (USD Million)
• Table 103 Asia Pacific Liquid Biopsy Market, By Country, 2021 - 2033 (USD Million)
• Table 104 Asia Pacific Liquid Biopsy Market, By Sample Type, 2021 - 2033 (USD Million)
• Table 105 Asia Pacific Liquid Biopsy Market, By Biomarker, 2021 - 2033 (USD Million)
• Table 106 Asia Pacific Liquid Biopsy Market, By Technology, 2021 - 2033 (USD Million)
• Table 107 Asia Pacific Liquid Biopsy Market, By Application, 2021 - 2033 (USD Million)
• Table 108 Asia Pacific Liquid Biopsy Market, By End Use, 2021 - 2033 (USD Million)
• Table 109 Asia Pacific Liquid Biopsy Market, By Clinical Application, 2021 - 2033 (USD Million)
• Table 110 Asia Pacific Liquid Biopsy Market, By Product, 2021 - 2033 (USD Million)
• Table 111 Japan Liquid Biopsy Market, By Sample Type, 2021 - 2033 (USD Million)
• Table 112 Japan Liquid Biopsy Market, By Biomarker, 2021 - 2033 (USD Million)
• Table 113 Japan Liquid Biopsy Market, By Technology, 2021 - 2033 (USD Million)
• Table 114 Japan Liquid Biopsy Market, By Application, 2021 - 2033 (USD Million)
• Table 115 Japan Liquid Biopsy Market, By End Use, 2021 - 2033 (USD Million)
• Table 116 Japan Liquid Biopsy Market, By Clinical Application, 2021 - 2033 (USD Million)
• Table 117 Japan Liquid Biopsy Market, By Product, 2021 - 2033 (USD Million)
• Table 118 China Liquid Biopsy Market, By Sample Type, 2021 - 2033 (USD Million)
• Table 119 China Liquid Biopsy Market, By Biomarker, 2021 - 2033 (USD Million)
• Table 120 China Liquid Biopsy Market, By Technology, 2021 - 2033 (USD Million)
• Table 121 China Liquid Biopsy Market, By Application, 2021 - 2033 (USD Million)
• Table 122 China Liquid Biopsy Market, By End Use, 2021 - 2033 (USD Million)
• Table 123 China Liquid Biopsy Market, By Clinical Application, 2021 - 2033 (USD Million)
• Table 124 China Liquid Biopsy Market, By Product, 2021 - 2033 (USD Million)
• Table 125 India Liquid Biopsy Market, By Sample Type, 2021 - 2033 (USD Million)
• Table 126 India Liquid Biopsy Market, By Biomarker, 2021 - 2033 (USD Million)
• Table 127 India Liquid Biopsy Market, By Technology, 2021 - 2033 (USD Million)
• Table 128 India Liquid Biopsy Market, By Application, 2021 - 2033 (USD Million)
• Table 129 India Liquid Biopsy Market, By End Use, 2021 - 2033 (USD Million)
• Table 130 India Liquid Biopsy Market, By Clinical Application, 2021 - 2033 (USD Million)
• Table 131 India Liquid Biopsy Market, By Product, 2021 - 2033 (USD Million)
• Table 132 Australia Liquid Biopsy Market, By Sample Type, 2021 - 2033 (USD Million)
• Table 133 Australia Liquid Biopsy Market, By Biomarker, 2021 - 2033 (USD Million)
• Table 134 Australia Liquid Biopsy Market, By Technology, 2021 - 2033 (USD Million)
• Table 135 Australia Liquid Biopsy Market, By Application, 2021 - 2033 (USD Million)
• Table 136 Australia Liquid Biopsy Market, By End Use, 2021 - 2033 (USD Million)
• Table 137 Australia Liquid Biopsy Market, By Clinical Application, 2021 - 2033 (USD Million)
• Table 138 Australia Liquid Biopsy Market, By Product, 2021 - 2033 (USD Million)
• Table 139 South Korea Liquid Biopsy Market, By Sample Type, 2021 - 2033 (USD Million)
• Table 140 South Korea Liquid Biopsy Market, By Biomarker, 2021 - 2033 (USD Million)
• Table 141 South Korea Liquid Biopsy Market, By Technology, 2021 - 2033 (USD Million)
• Table 142 South Korea Liquid Biopsy Market, By Application, 2021 - 2033 (USD Million)
• Table 143 South Korea Liquid Biopsy Market, By End Use, 2021 - 2033 (USD Million)
• Table 144 South Korea Liquid Biopsy Market, By Clinical Application, 2021 - 2033 (USD Million)
• Table 145 South Korea Liquid Biopsy Market, By Product, 2021 - 2033 (USD Million)
• Table 146 Thailand Liquid Biopsy Market, By Sample Type, 2021 - 2033 (USD Million)
• Table 147 Thailand Liquid Biopsy Market, By Biomarker, 2021 - 2033 (USD Million)
• Table 148 Thailand Liquid Biopsy Market, By Technology, 2021 - 2033 (USD Million)
• Table 149 Thailand Liquid Biopsy Market, By Application, 2021 - 2033 (USD Million)
• Table 150 Thailand Liquid Biopsy Market, By End Use, 2021 - 2033 (USD Million)
• Table 151 Thailand Liquid Biopsy Market, By Clinical Application, 2021 - 2033 (USD Million)
• Table 152 Thailand Liquid Biopsy Market, By Product, 2021 - 2033 (USD Million)
• Table 153 Latin America Liquid Biopsy Market, By Country, 2021 - 2033 (USD Million)
• Table 154 Latin America Liquid Biopsy Market, By Sample Type, 2021 - 2033 (USD Million)
• Table 155 Latin America Liquid Biopsy Market, By Biomarker, 2021 - 2033 (USD Million)
• Table 156 Latin America Liquid Biopsy Market, By Technology, 2021 - 2033 (USD Million)
• Table 157 Latin America Liquid Biopsy Market, By Application, 2021 - 2033 (USD Million)
• Table 158 Latin America Liquid Biopsy Market, By End Use, 2021 - 2033 (USD Million)
• Table 159 Latin America Liquid Biopsy Market, By Clinical Application, 2021 - 2033 (USD Million)
• Table 160 Latin America Liquid Biopsy Market, By Product, 2021 - 2033 (USD Million)
• Table 161 Brazil Liquid Biopsy Market, By Sample Type, 2021 - 2033 (USD Million)
• Table 162 Brazil Liquid Biopsy Market, By Biomarker, 2021 - 2033 (USD Million)
• Table 163 Brazil Liquid Biopsy Market, By Technology, 2021 - 2033 (USD Million)
• Table 164 Brazil Liquid Biopsy Market, By Application, 2021 - 2033 (USD Million)
• Table 165 Brazil Liquid Biopsy Market, By End Use, 2021 - 2033 (USD Million)
• Table 166 Brazil Liquid Biopsy Market, By Clinical Application, 2021 - 2033 (USD Million)
• Table 167 Brazil Liquid Biopsy Market, By Product, 2021 - 2033 (USD Million)
• Table 168 Argentina Liquid Biopsy Market, By Sample Type, 2021 - 2033 (USD Million)
• Table 169 Argentina Liquid Biopsy Market, By Biomarker, 2021 - 2033 (USD Million)
• Table 170 Argentina Liquid Biopsy Market, By Technology, 2021 - 2033 (USD Million)
• Table 171 Argentina Liquid Biopsy Market, By Application, 2021 - 2033 (USD Million)
• Table 172 Argentina Liquid Biopsy Market, By End Use, 2021 - 2033 (USD Million)
• Table 173 Argentina Liquid Biopsy Market, By Clinical Application, 2021 - 2033 (USD Million)
• Table 174 Argentina Liquid Biopsy Market, By Product, 2021 - 2033 (USD Million)
• Table 175 Middle East & Africa Liquid Biopsy Market, By Country, 2021 - 2033 (USD Million)
• Table 176 Middle East & Africa Liquid Biopsy Market, By Sample Type, 2021 - 2033 (USD Million)
• Table 177 Middle East & Africa Liquid Biopsy Market, By Biomarker, 2021 - 2033 (USD Million)
• Table 178 Middle East & Africa Liquid Biopsy Market, By Technology, 2021 - 2033 (USD Million)
• Table 179 Middle East & Africa Liquid Biopsy Market, By Application, 2021 - 2033 (USD Million)
• Table 180 Middle East & Africa Liquid Biopsy Market, By End Use, 2021 - 2033 (USD Million)
• Table 181 Middle East & Africa Liquid Biopsy Market, By Clinical Application, 2021 - 2033 (USD Million)
• Table 182 Middle East & Africa Liquid Biopsy Market, By Product, 2021 - 2033 (USD Million)
• Table 183 South Africa Liquid Biopsy Market, By Sample Type, 2021 - 2033 (USD Million)
• Table 184 South Africa Liquid Biopsy Market, By Biomarker, 2021 - 2033 (USD Million)
• Table 185 South Africa Liquid Biopsy Market, By Technology, 2021 - 2033 (USD Million)
• Table 186 South Africa Liquid Biopsy Market, By Application, 2021 - 2033 (USD Million)
• Table 187 South Africa Liquid Biopsy Market, By End Use, 2021 - 2033 (USD Million)
• Table 188 South Africa Liquid Biopsy Market, By Clinical Application, 2021 - 2033 (USD Million)
• Table 189 South Africa Liquid Biopsy Market, By Product, 2021 - 2033 (USD Million)
• Table 190 Saudi Arabia Liquid Biopsy Market, By Sample Type, 2021 - 2033 (USD Million)
• Table 191 Saudi Arabia Liquid Biopsy Market, By Biomarker, 2021 - 2033 (USD Million)
• Table 192 Saudi Arabia Liquid Biopsy Market, By Technology, 2021 - 2033 (USD Million)
• Table 193 Saudi Arabia Liquid Biopsy Market, By Application, 2021 - 2033 (USD Million)
• Table 194 Saudi Arabia Liquid Biopsy Market, By End Use, 2021 - 2033 (USD Million)
• Table 195 Saudi Arabia Liquid Biopsy Market, By Clinical Application, 2021 - 2033 (USD Million)
• Table 196 Saudi Arabia Liquid Biopsy Market, By Product, 2021 - 2033 (USD Million)
• Table 197 UAE Liquid Biopsy Market, By Sample Type, 2021 - 2033 (USD Million)
• Table 198 UAE Liquid Biopsy Market, By Biomarker, 2021 - 2033 (USD Million)
• Table 199 UAE Liquid Biopsy Market, By Technology, 2021 - 2033 (USD Million)
• Table 200 UAE Liquid Biopsy Market, By Application, 2021 - 2033 (USD Million)
• Table 201 UAE Liquid Biopsy Market, By End Use, 2021 - 2033 (USD Million)
• Table 202 UAE Liquid Biopsy Market, By Clinical Application, 2021 - 2033 (USD Million)
• Table 203 UAE Liquid Biopsy Market, By Product, 2021 - 2033 (USD Million)
• Table 204 Kuwait Liquid Biopsy Market, By Sample Type, 2021 - 2033 (USD Million)
• Table 205 Kuwait Liquid Biopsy Market, By Biomarker, 2021 - 2033 (USD Million)
• Table 206 Kuwait Liquid Biopsy Market, By Technology, 2021 - 2033 (USD Million)
• Table 207 Kuwait Liquid Biopsy Market, By Application, 2021 - 2033 (USD Million)
• Table 208 Kuwait Liquid Biopsy Market, By End Use, 2021 - 2033 (USD Million)
• Table 209 Kuwait Liquid Biopsy Market, By Clinical Application, 2021 - 2033 (USD Million)
• Table 210 Kuwait Liquid Biopsy Market, By Product, 2021 - 2033 (USD Million)

List of Figures

• Fig. 1 Market research process
• Fig. 2 Information procurement
• Fig. 3 Primary research pattern
• Fig. 4 Market research approaches
• Fig. 5 Value chain-based sizing & forecasting
• Fig. 6 Market formulation & validation
• Fig. 7 Liquid biopsy market segmentation
• Fig. 8 Market driver relevance analysis (Current & future impact)
• Fig. 9 Market restraint relevance analysis (Current & future impact)
• Fig. 10 Market challenge relevance analysis (Current & future impact)
• Fig. 11 Penetration & growth prospect mapping
• Fig. 12 SWOT analysis, by factor (political & legal, economic and technological)
• Fig. 13 Porter's five forces analysis
• Fig. 14 Market penetration vs growth prospect mapping
• Fig. 15 Liquid biopsy market: Sample Type movement analysis
• Fig. 16 Blood sample liquid biopsy market, 2021 - 2033 (USD Million)
• Fig. 17 Others liquid biopsy market, 2021 - 2033 (USD Million)
• Fig. 18 Liquid biopsy market: Biomarker movement analysis
• Fig. 19 Circulating Tumor Cells (CTCs) liquid biopsy market, 2021 - 2033 (USD Million)
• Fig. 20 Circulating Nucleic Acids liquid biopsy market, 2021 - 2033 (USD Million)
• Fig. 21 Exosomes/Microvesicles liquid biopsy market, 2021 - 2033 (USD Million)
• Fig. 22 Others liquid biopsy market, 2021 - 2033 (USD Million)
• Fig. 23 Liquid biopsy market: Technology movement analysis
• Fig. 24 Multi-gene-parallel analysis (NGS) liquid biopsy market, 2021 - 2033 (USD Million)
• Fig. 25 Single gene analysis (PCR Microarrays) liquid biopsy market, 2021 - 2033 (USD Million)
• Fig. 26 Liquid biopsy market: Application movement analysis
• Fig. 27 Cancer liquid biopsy market, 2021 - 2033 (USD Million)
• Fig. 28 Lung cancer liquid biopsy market, 2021 - 2033 (USD Million)
• Fig. 29 Prostate cancer liquid biopsy market, 2021 - 2033 (USD Million)
• Fig. 30 Breast cancer liquid biopsy market, 2021 - 2033 (USD Million)
• Fig. 31 Colorectal cancer liquid biopsy market, 2021 - 2033 (USD Million)
• Fig. 32 Leukemia liquid biopsy market, 2021 - 2033 (USD Million)
• Fig. 33 Gastrointestinal cancer liquid biopsy market, 2021 - 2033 (USD Million)
• Fig. 34 Others liquid biopsy market, 2021 - 2033 (USD Million)
• Fig. 35 Reproductive Health liquid biopsy market, 2021 - 2033 (USD Million)
• Fig. 36 Others liquid biopsy market, 2021 - 2033 (USD Million)
• Fig. 37 Liquid biopsy market: End Use movement analysis
• Fig. 38 Hospitals and Laboratories liquid biopsy market, 2021 - 2033 (USD Million)
• Fig. 39 Specialty clinics liquid biopsy market, 2021 - 2033 (USD Million)
• Fig. 40 Academic and research centers liquid biopsy market, 2021 - 2033 (USD Million)
• Fig. 41 Others liquid biopsy market, 2021 - 2033 (USD Million)
• Fig. 42 Liquid biopsy market: Clinical application movement analysis
• Fig. 43 Therapy selection liquid biopsy market, 2021 - 2033 (USD Million)
• Fig. 44 Treatment monitoring liquid biopsy market, 2021 - 2033 (USD Million)
• Fig. 45 Early cancer screening liquid biopsy market, 2021 - 2033 (USD Million)
• Fig. 46 Recurrence monitoring liquid biopsy market, 2021 - 2033 (USD Million)
• Fig. 47 Others liquid biopsy market, 2021 - 2033 (USD Million)
• Fig. 48 Liquid biopsy market: Product movement analysis
• Fig. 49 Instruments liquid biopsy market, 2021 - 2033 (USD Million)
• Fig. 50 Consumables kits and reagents liquid biopsy market, 2021 - 2033 (USD Million)
• Fig. 51 Software and Services liquid biopsy market, 2021 - 2033 (USD Million)
• Fig. 52 Regional marketplace: Key takeaways
• Fig. 53 Regional outlook, 2021 & 2033
• Fig. 54 North America liquid biopsy market, 2021 - 2033 (USD Million)
• Fig. 55 U.S. liquid biopsy market, 2021 - 2033 (USD Million)
• Fig. 56 Canada liquid biopsy market, 2021 - 2033 (USD Million)
• Fig. 57 Mexico liquid biopsy market, 2021 - 2033 (USD Million)
• Fig. 58 Europe liquid biopsy market, 2021 - 2033 (USD Million)
• Fig. 59 UK liquid biopsy market, 2021 - 2033 (USD Million)
• Fig. 60 Germany liquid biopsy market, 2021 - 2033 (USD Million)
• Fig. 61 Italy liquid biopsy market, 2021 - 2033 (USD Million)
• Fig. 62 Spain liquid biopsy market, 2021 - 2033 (USD Million)
• Fig. 63 France liquid biopsy market, 2021 - 2033 (USD Million)
• Fig. 64 Denmark liquid biopsy market, 2021 - 2033 (USD Million)
• Fig. 65 Sweden liquid biopsy market, 2021 - 2033 (USD Million)
• Fig. 66 Norway liquid biopsy market, 2021 - 2033 (USD Million)
• Fig. 67 Asia Pacific liquid biopsy market, 2021 - 2033 (USD Million)
• Fig. 68 Japan liquid biopsy market, 2021 - 2033 (USD Million)
• Fig. 69 China liquid biopsy market, 2021 - 2033 (USD Million)
• Fig. 70 India liquid biopsy market, 2021 - 2033 (USD Million)
• Fig. 71 Australia liquid biopsy market, 2021 - 2033 (USD Million)
• Fig. 72 South Korea liquid biopsy market, 2021 - 2033 (USD Million)
• Fig. 73 Thailand liquid biopsy market, 2021 - 2033 (USD Million)
• Fig. 74 Latin America liquid biopsy market, 2021 - 2033 (USD Million)
• Fig. 75 Brazil liquid biopsy market, 2021 - 2033 (USD Million)
• Fig. 76 Argentina liquid biopsy market, 2021 - 2033 (USD Million)
• Fig. 77 Middle East and Africa liquid biopsy market, 2021 - 2033 (USD Million)
• Fig. 78 South Africa liquid biopsy market, 2021 - 2033 (USD Million)
• Fig. 79 Saudi Arabia liquid biopsy market, 2021 - 2033 (USD Million)
• Fig. 80 UAE liquid biopsy market, 2021 - 2033 (USD Million)
• Fig. 81 Kuwait liquid biopsy market, 2021 - 2033 (USD Million)